1h-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- has been researched along with pargyline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altar, CA; Boyar, WC; Gerhardt, SC; Liebman, JM; Wasley, A; Wood, PL | 1 |
1 other study(ies) available for 1h-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- and pargyline
Article | Year |
---|---|
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Brain Chemistry; Dopamine; Dopamine Antagonists; Male; Mice; Motor Activity; Pargyline; Stereotyped Behavior | 1988 |